Lexicon Pharmaceuticals | LXRX - Azione





Azione Cambiamento Data
Abbott USD 6.99B 501M 2026-03
Acadia Pharmaceuticals USD 31.57M 3.1M 2026-03
Agios Pharmaceuticals USD 35.75M 665K 2026-06
Akebia Therapeutics USD 13M 2.61M 2026-03
Alnylam Pharmaceuticals USD 97.11M 103.04M 2026-06
AstraZeneca USD 6.93B 362M 2026-06
BioMarin Pharmaceutical USD 1.27B 25.66M 2026-03
Coherus Biosciences USD 3.17M 1.12M 2025-12
Eli Lilly USD 14.53B 785M 2026-03
Halozyme Therapeutics USD 155.47M 21.01M 2026-03
Illumina USD 629M 18M 2026-06
Insmed USD 132.91M 841K 2026-03
J&J USD 15.14B 561M 2026-06
Lexicon Pharmaceuticals USD 276K 5K 2026-03
MacroGenics USD 9.5M 1.59M 2026-03
MannKind USD 49.17M 13.85M 2026-03
Merck USD 6.48B 179M 2026-03
Moderna USD 280M 134M 2026-06
Novartis USD 6.22B 66M 2026-06
PTC Therapeutics USD 91.35M 15.79M 2026-06
Puma Biotechnology USD 9.48M 885K 2025-09
Sarepta Therapeutics USD 1B 86.37M 2026-03
Thermo Fisher Scientific USD 5.5B 71M 2026-03
Ultragenyx Pharmaceutical USD 55M 3M 2026-03
United Therapeutics USD 178.3M 4.8M 2026-03
Vanda Pharmaceuticals USD 1.85M 190K 2025-12